see optimistic view vanda iloperidone read article red herring snippet thomas weisel analyst donald ellis agrees vanda superior atypical antipsychotic drugs less frequent incidence side effects iloperidone differentiated existing atypical antipsychotics lower incidence weight gain diabetes extrapyramidal symptoms involuntary body movements sedation impaired cognition believe vanda well positioned potential acquisition major pharmaceutical company wrote research note sales atypical antipsychotics reaching billion percent increase iloperidone looks great boon vanda bank america analyst maris projects iloperidone garner million sales vanda successful results trial vanda likely file new drug application fda launch sales iloperidone iloperidone looks attractive safety profile writes attractive safety profile line used prior release nearly every new medication though actual safety profile seen current lineup atypical antipsychotics different story maybe i wrong iloperidone despite languishing years development single publicly available efficacy trial next big thing schizophrenia iloperidone